申请人:Gunay Nur Sibel
公开号:US20140114056A1
公开(公告)日:2014-04-24
Methods of evaluating heparin preparations, e.g., for suitability for use as a drug or for use in making a drug, by determining the absence, presence or amount of a structural signature, wherein, e.g., the structural signature is indicative of the methods used to make the heparin preparation.